| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,508 |
3,020 |
$238K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,868 |
3,543 |
$167K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
240 |
196 |
$17K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
142 |
114 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
435 |
412 |
$7K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
30 |
25 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
12 |
12 |
$421.08 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
30 |
27 |
$416.16 |
| 81002 |
|
112 |
104 |
$288.60 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
15 |
12 |
$147.15 |
| 81003 |
|
14 |
12 |
$30.52 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
14 |
12 |
$1.89 |